Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's Disease
Launched by UNIVERSITY OF ULSTER · Nov 19, 2024
Trial Information
Current as of September 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new functional drink designed to help people with Parkinson's disease (PD) who often suffer from constipation. Constipation is a common problem for many individuals with PD, affecting up to 80% of them. The researchers believe that adding more fiber to the diet can improve this issue, and they have created a drink enriched with inulin, a type of fiber found in vegetables, along with important vitamins like B-vitamins and vitamin D that may also support overall health in people with PD. The trial will last 12 weeks and aims to see how this drink impacts gut health, nutrition, and quality of life.
To join the study, participants must be at least 18 years old and have a diagnosis of Parkinson's disease. However, those living in care facilities, with certain health conditions like diabetes, or who are taking specific medications or supplements may not be eligible. Participants will consume the functional drink and may share their experiences regarding any improvements in their symptoms or overall well-being. This trial is an exciting opportunity to explore how dietary changes can make a difference for those living with Parkinson's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Parkinson Disease (PD)
- • Aged ≥18 years
- • Individuals with the capacity to provide informed consent
- Exclusion Criteria:
- • Individuals with PD living in institutional care or in hospital
- • Drug, infection or toxin induced parkinsonism
- • Individuals with diabetes
- • B12 injection users
- • Currently taking antibiotics
- • Using supplements containing the nutrients of interest (B-vitamins, inulin, probiotics)
- • Any other medical, cognitive or psychosocial issue, or co-enrolment in another study, that could interfere or disrupt adherence to the study requirements
- • An allergy to any of the ingredients in the functional and/or control drinks
- • Consuming a fermented food and/or probiotic yogurts on a daily basis
About University Of Ulster
The University of Ulster is a leading academic institution dedicated to advancing knowledge and innovation through research and education. Renowned for its commitment to excellence, the university actively engages in clinical trials aimed at improving healthcare outcomes and addressing pressing health challenges. With a robust infrastructure for research and a multidisciplinary approach, the University of Ulster fosters collaboration among researchers, healthcare professionals, and industry partners. Its focus on evidence-based practices ensures that clinical trials are designed and conducted to the highest ethical and scientific standards, contributing valuable insights to the field of medicine and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coleraine, County Londonderry, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported